Αρχική Σελίδα – ΕΔΕ – Ελληνική Διαβητολογική Εταιρεία

4 Ιουνίου 2026

Webinar ΕΔΕ για το κοινό (29/6/2026, 20:30)

ΟΜΙΛΙΕΣ:

1) Διαχείριση του σακχαρώδους διαβήτη τους θερινούς μήνες
Ασημίνα Γανωτοπούλου, ειδικός Παθολόγος – Διαβητολόγος, Διδάκτωρ Ιατρικής Σχολής Πανεπιστημίου Αθηνών, Επιστ. Συνεργάτης Διαβητολογικού Κέντρου Γ.Ν. “Τζάνειο”, Πειραιάς.

2) Διαβητικό πόδι: τι πρέπει να γνωρίζει το άτομο με διαβήτη.
Νικόλαος Παπάνας, Καθηγητής Παθολογίας-Σακχαρώδους Διαβήτη, Υπεύθυνος Διαβητολογικού Κέντρου-Ιατρείου Διαβητικού ποδιού, Β’ Πανεπιστημιακή Παθολογική Κλινική Δημοκρίτειου Πανεπιστημίου Θράκης, τ. Πρόεδρος Ευρωπαϊκής Ομάδας Μελέτης Διαβητικού Ποδιού, Αντιπρόεδρος Εταιρείας Μελέτης Παθήσεων Διαβτηικού Ποδιού.

Σύνδεσμος ελεύθερης εγγραφής στο webinar: https://us06web.zoom.us/webinar/register/WN_bZb4OIyGQkmyMVBiY9VURA

Προσβλέποντας πάντα στην πολύτιμη ενεργό συμμετοχή σας.

Ο Πρόεδρος της Ε.Δ.Ε.
Κ. Μακρυλάκης

Ο Γεν. Γραμματέας της Ε.Δ.Ε.
Σ. Λιάτης

3 Ιουνίου 2026

ΕΔΕ Αρχική Σελίδα, Νέα και Ανακοινώσεις

IDF Europe newsletter – May 2026

Accelerating diabetes innovation in Europe:

getting it right for people living with diabetes

Diabetes is a complex, lifelong condition requiring 24/7 self-management across every aspect of daily life. To manage their condition, people living with diabetes (PwD) need access to a range of products and services, including insulin and other medicines, self-management technologies and supplies, structured education, mental health support, regular screening for complications and integrated, person-centred care. Over the past years, innovations such as continuous glucose monitoring (CGM) and advanced insulin delivery systems, digital health tools, new therapies and screening approaches have significantly improved the lives of PwD. However, many unmet needs remain across the full spectrum of diabetes care from primary prevention and early
detection to more effective management and treatment options, better secondary prevention and management of complications and, critically, a cure remains unavailable.

Promising new approaches have emerged that could transform diabetes prevention and care in the coming decades and help address these unmet needs. These include, for example, cell and gene-based replacement therapies, next-generation insulins and novel AI-driven technologies, all of which hold real potential to significantly improve quality of life for PwD.

Europe is uniquely positioned to lead this new wave of
innovation. Across the region, world-class expertise and leading research and clinical centres are already driving advances in diabetes prevention, management and care. Yet, complex, fragmented regulatory and funding landscapes, uneven implementation across countries and delays in translating scientific breakthroughs into real-world solutions are slowing down progress and limiting the uptake of these new innovations. The challenge is not a lack of knowledge or capacity, but ensuring that the right structures are in place to turn this excellence into impact.

This is where the EU Biotech Act, currently under development at EU level, becomes a pivotal opportunity. The legislation will help define the future
framework for biotechnology innovation in Europe, including the development of therapies and technologies that millions of PwD will rely on in the years ahead. By streamlining regulatory pathways, reducing fragmentation and enabling more efficient clinical development and manufacturing, it has the potential to significantly accelerate the translation of scientific breakthroughs into clinical practice.

If designed with people at the centre and a focus on accessibility, affordability and equity, it can strengthen Europe’s position in biomedical innovation and ensure that people benefit from new therapies more quickly and more equitably.

This means ensuring that people with lived experience are meaningfully involved in shaping the direction of innovation, that new therapies translate into real improvements in daily life and that their access is made equal within and between countries. It also requires a clearer focus on where innovation is most needed, ensuring that research and investment are directed towards addressing real unmet needs.

Europe has the capacity to lead the next era of diabetes care, but real success will depend on getting it right: ensuring that innovation reaches the people it is meant to serve and that people with lived experience are engaged from the start.

Martina Boccardo
IDF Strategic Communications and Content Coordinator

Carmen Hurtado del Pozo
BreakthroughT1D Director, European Research

IDF EUROPE, NEWS, ACTIVITIES AND EVENTS

Diabetes Ireland Conference & Exhibition 2026

IDF Europe was pleased to participate in the Diabetes Ireland Conference & Exhibition 2026 (DICE2026), represented by Sabine Dupont, Director of Strategy and Policy. The event brought together HCPs, policymakers and diabetes stakeholders to discuss the future of diabetes care in Ireland.

A key highlight of the conference was the launch of the National Diabetes Policy and Services Review by Minister for Health Dr Jennifer Carroll MacNeill TD, setting out priorities for diabetes care in the years ahead.

Discussions focused on adult, paediatric and gestational diabetes, innovation in care, and the integration of services to improve outcomes for PwD.

WHO/Europe’s Public Health Innovation Platform

IDF Europe is pleased to be part of the WHO/Europe Public Health Innovation Platform, a collaborative initiative bringing together representatives from patient organisations, civil society, academia, industry and public health authorities from across the Region to advance public health innovation.

As healthcare systems face increasingly complex challenges, innovation plays a key role in strengthening prevention, improving care pathways and promoting more resilient and equitable health systems.

Through this platform, IDF Europe will share insights from the diabetes community, exchange knowledge with partners and contribute to the development of innovative approaches that can improve the lives of PwD and other chronic conditions across Europe.

IDF Europe at the “Economics of Obesity and Metabolic Health Summit”

IDF Europe’s Regional Manager, Elisabeth Dupont, will speak at the “Economics of Obesity and Metabolic Health Summit” on June 10 at 17:00 in Brussels, taking part in the panel “How can multi-system interventions transform metabolic health?”. The session will explore how socio-economic status, food systems and the built environment contribute to obesity and metabolic risk, and how fiscal, regulatory and educational measures can help create healthier environments and improve prevention and care outcomes.

The summit will bring together policymakers, researchers and other stakeholders to discuss the economic and social impact of obesity and metabolic health, and to identify effective cross-sector solutions.

Building community consensus for multiple

interconected chronic conditions

On May 19, a multi-stakeholder, lived-experience-led meeting was hosted by Global Heart Hub and The George Institute for Global Health in Zurich.

The event focused on improving integrated care for people living with multiple long-term health conditions.

The discussions brought together organisations from across the non-communicable disease (NCD) community to explore more coordinated, person-centred approaches to care for conditions such as diabetes, cardiovascular disease, kidney and liver diseases.

Representatives from IDF Global and IDF Europe, Sameer Pathan and Elisabeth Dupont, shared insights from European integrated care initiatives and highlighted the importance of stronger primary care, HCP education, the
use of digital health tools and multidisciplinary collaboration in advancing integrated cardiometabolic care. Advocates with lived experience also contributed their perspectives, reinforcing the importance of involving people living with chronic conditions in healthcare discussions and decision-making.

Honouring the legacy of Anne Marie Felton: a tireless advocate for diabetes care in Europe

It is with great sadness that we share the news of the passing of Anne Marie Felton, who dedicated more than three decades to advancing diabetes education and improving care for PwD across Europe and beyond. A diabetes specialist nurse and founding member of the Foundation of European Nurses in Diabetes (FEND), she played a pivotal role in strengthening the voice of diabetes nurses and shaping diabetes policy and education at both European and global level.

Her longstanding contribution to the wider diabetes community leaves a lasting legacy that will continue to inspire future generations.

MEMBER NEWS

FFD releases landmark report on the rights of people living with T1D in France

The Fédération Française des Diabétique (FFD) has published a landmark report on the rights of people living with T1D in France, examining the legal and social protections currently in place and where gaps still remain.

The report highlights how PwD face barriers in areas such as employment, driving, insurance and access to certain opportunities, often due to outdated automatic exclusions rather than individual medical assessment.

It calls for the recognition of equal rights and a more personalised approach to decision making, ensuring PwD receive fair treatment in everyday life. okoko

JUJUJU

APDP marks 100 years of pioneering diabetes care and advocacy

The Portuguese Diabetes Association (APDP) marked its 100th anniversary with a commemorative ceremony held in Lisbon at the Portuguese Parliament, bringing together policymakers, HCPs, international partners and diabetes advocates to celebrate a century of pioneering work in diabetes care and advocacy.

The event highlighted APDP’s historical contribution to improving access to insulin, advancing person-centred care, and promoting education and social inclusion for PwD.

Speakers reflected on the organisation’s evolution from its founding in 1926 to its current role as a leading centre for integrated diabetes care and innovation.

Submit a nomination for the 2026-28 cohort of the Young Leaders in Diabetes (YLD) Programme

The Young Leaders in Diabetes (YLD) Programme was established by the International Diabetes Federation to empower young PwD to champion their cause and represent others globally living with the condition.

We are pleased to announce that IDF has opened applications for the new YLD Cohort 2026.

We invite you to nominate up to two candidates in this link:

https://mailchi.mp/idf/yld-nomination-2026-en

Join us for an information webinar to find out more about the programme and for participants to be guided through the nomination and application process on May 29 from 14:00 to 16:30 CEST.

IDF Europe at the San Marino Diabetes Congress

On May 29–30, the San Marino Association of People with Diabetes, Vivere Meglio (“Living Better”), organised an international congress focused on advancing person-centred diabetes care. The programme was co-developed by IDF Europe in collaboration with the Congress President, Riccardo Venturini, and the Scientific Lead, Paolo Di Bartolo.

The event brought together diabetes advocates, HCPs, national associations and other experts to exchange perspectives on the future of diabetes care. Discussions focused on high-quality, integrated and person-centred care, the role of key stakeholders, the social impact of diabetes, and the importance of innovation, equity and personalised approaches to care. IDF Europe’s representatives, Prof. Tadej Battelino, Stella de Sabata and Martina Boccardo, joined the event, and presented IDFE’s work on advancing PwD’s rights and amplifying the voice of diabetes community in policy, research and advocacy.

We thank Vivere Meglio for their collaboration and are pleased to welcome them as a new IDF provisional member. We look forward to building on this successful cooperation and deepening our engagement in the future.

YOUTH PLATFORM

Mentors’ weekend

The Mentors’ Weekend for the IDF Europe Youth Leadership Lab (YLL) 2026 took place in Brussels from May 1–3, bringing together mentors ahead of this year’s YLL to be held in Portugal. The weekend combined team-building activities, practical workshops and planning sessions designed to prepare mentors for their role in supporting young diabetes advocates throughout the YLL journey.

A key focus was strengthening collaboration, aligning on programme objectives, and
equipping mentors with the tools needed to facilitate peer learning, leadership development and inclusive group work. The sessions also reinforced the importance of shared experience and guidance in empowering the next generation of advocates within the diabetes community.

The IDF Europe T2D training has officially started

On May 26, IDF Europe officially launched the T2GETHER Training Programme, a new pilot initiative designed to empower people living with type 2 diabetes (T2D) to become confident and effective advocates.

Co-created with members of the T2GETHER community, the programme combines expert-led training, peer exchange and practical advocacy skills development.

Through six modules
running from May to October 2026, participants will explore topics such as understanding what is T2D and how its complications develop, advocacy basics including storytelling, project development and the use of data, while also learning how to use their lived experience to drive positive change. ggog

MMD NEWS

The MMD Group welcomes MEP Daniel Attard (S&D, Malta)

The MMD Group is pleased to welcome Member of the European Parliament (MEP) Daniel Attard (S&D, Malta) as a new member. MEP Attard serves as Vice-Chair of the Delegation for relations with Iran and is an active member of several key parliamentary committees, including TRAN, ITRE and REGI, as well as multiple delegations focused on international relations.

With a background in diplomacy, local government and journalism, he brings extensive experience to his work in the European Parliament. A strong advocate for youth empowerment, MEP
Attard is committed to ensuring that young people, particularly those living with T1D, are meaningfully involved in decision-making processes.

We look forward to his contribution to advancing inclusive and patient-centred policies across Europe.

WHAT WE ARE READING

Diabetes-related complications: an evolving spectrum – The Lancet Diabetes & Endocrinology

Diabetes complications are increasingly understood as a complex and evolving spectrum, reflecting the growing impact of multimorbidity and long-term metabolic risk. The article highlights the need for more integrated, preventive and patient-centred approaches to care, as well as health systems that can better respond to the changing reality of diabetes management. Read more

Ireland strengthens equitable access to assistive technology – WHO assessment

Ireland is making progress in improving equitable access to assistive technology, according to a new WHO assessment. The findings highlight steps taken to strengthen policy and service delivery, while also pointing to remaining challenges around affordability and availability. Ensuring access to assistive technology remains key to advancing inclusion and universal health coverage. Read more

CGM vs self-monitoring in T2D – The Lancet Diabetes & Endocrinology

New evidence from a randomised clinical trial adds to existing research showing that CGM improves glycaemic management compared to traditional self-monitoring in people with T2D. These findings further support the role of digital tools in enabling more personalised and effective diabetes care. Read more. Read more

UNDERSTANDING DIABETES

World No Tobacco Day

On May 31, World No Tobacco Day served as a reminder of the strong link between tobacco use and T2D. Smoking has been shown not only to increase the risk of developing T2D, but also to worsen diabetes-related complications, including cardiovascular disease, kidney disease, nerve damage and vision impairment.

As part of the European Chronic Disease Alliance (ECDA), we continued to advocate for stronger policies addressing shared risk factors and promoting healthier environments for all. Reducing tobacco use remains essential to improving public health
outcomes and supporting prevention efforts across Europe.

Evidence also showed that quitting smoking leads to significant health benefits, including improved diabetes management and a reduced risk of long-term complications. People who smoke should have access to effective cessation support and integrated healthcare services to help them successfully quit smoking. JKJKJKJKJKJK

European Public Health Week

During the European Public Health Week (May 4–8), we highlighted several key themes reflecting the broader challenges and priorities linked to diabetes and NCD across Europe.

The discussions focused on the importance of equity-driven public health investment, recognising how social determinants such as income, education and access to care strongly influence diabetes outcomes and overall health.

Mental
health was also highlighted as a key component of diabetes care, underlining the need for more integrated support that addresses both physical and psychological well-being.

In addition, IDF Europe stressed the importance of meaningful engagement of PwD in research, policy and decision-making processes to strengthen trust, accountability and more person-centred healthcare systems.

International Nurses Day

On International Nurses Day (May 12) we recognised the essential role nurses play in diabetes care. For PwD, diabetes specialist nurses (DSNs) are often at the heart of care, providing education, guidance, treatment support and continuity throughout every stage of the diabetes journey.

As diabetes prevalence continues to rise across Europe, strong multidisciplinary healthcare teams are essential to deliver integrated, person-centred care.

DNSs play a critical role within these teams, supporting PwD through education, from medication and self-management to lifestyle changes and prevention and management of complications, and providing essential psychological support.

At IDF Europe, we call for greater recognition, support and investment in the diabetes healthcare workforce, including DNSs, to strengthen healthcare systems and improve diabetes care across Europe.
JIJIJIJIJIJJI

World Hypertension Day

On World Hypertension Day (May 17), we raised awareness of hypertension (HTN), a major risk factor for cardiovascular disease that is frequently observed alongside diabetes and contributes to increased health risks. It is also one of the leading causes of premature death worldwide.

It can develop silently over time without noticeable symptoms, making prevention, early detection and effective management essential.

Healthy lifestyles, regular monitoring and access to quality healthcare can significantly reduce its impact.

PwD are around twice as likely to develop high blood pressure, increasing the risk of serious diabetes-related complications such as heart disease, stroke and kidney disease.
DigiCare4You – A Horizon 2020 Project is an example of an initiative aiming to improve the early prevention and management of HTN and T2D through community-based, person-centred digital solutions.

EU RESEARCH PROJECTS

ASSESS DHT

Join the ASSESS DHT Open Consultation and shape our digital health technologies (DHTs) assessment framework!

DHTs, including apps, telehealth solutions and AI-based tools, are becoming a central part of Europe’s health systems.

However, approaches to assessing their value, safety and impact vary across countries and are not always adapted to fast-evolving technologies.

The ASSESS DHT project is developing a European framework, toolkit and manual to support the assessment of DHTs across their full lifecycle. Stakeholders are now invited to participate in an open public consultation to help shape this framework and ensure it is relevant, feasible and adaptable across different contexts.

Join the open consultation and help us shape the future of DHT assessment in
Europe. The open consultation will be available until June 20.

Watch the ISLET webinar: “What we did, what we learned and what comes next”

On May 18, we held a webinar showcasing the ISLET project, a Horizon 2020 project aiming to advance on cell-based therapies for TD1.

The webinar explored the progress made so far in T1D research, the current challenges facing islet transplantation and stem cell therapies, including funding, accesibility and inmmunosuppression, as well as the importance of keeping the perspectives of PwD at the centre of innovation.

The webinar sparked usefull conversations highlighting that advancing diabetes care requires not only scientific innovation, but also collaboration, empathy and the meaningful involvement of lived experience. okokoko

Watch the webinar

DigiCare4You updates

IDF Europe is proud to be part of the DigiCare4You Horizon 2020 project, which aims to improve early prevention and management of T2D and HTN.

DigiCare4You final event’s video

Discover the key moments from the second DigiCare4You workshop in a new video, showcasing the final event held on April 29 in Brussels. Bringing together policymakers, public health leaders, healthcare experts and PwD, the event explored innovative solutions for the prevention and management of T2D and HTN, as well as opportunities for future implementation at national level.

Watch the video

Webinar: “From pilot to policy: scaling
DigiCare4You for better NCD Care”

The DigiCare4You interactive webinar, held on May 19, brought together experts and stakeholders to explore how the project is moving beyond pilot initiatives toward real policy-level impact in the prevention and management of NCD such as T2D and HTN.

The session showcased key findings and results from the project, alongside practical insights into how digital health interventions can be implemented and scaled within national health systems. Through expert presentations and dynamic discussions, participants exchanged views on both the challenges and
opportunities of integrating digital solutions into NCD prevention and management strategies.

DiaPs: a new digital peer support tool for sport and diabetes

We are excited to support the launch of DiaPS, a new digital peer-support app designed to empower people living with T1D to participate in sport safely and confidently. Developed as part of the EU-funded DiaPS project, the app was co-created with people living with T1D and brings together athletes, coaches, HCPs, families and researchers in one dedicated space.

The app offers trusted information on sport and diabetes, peer-to-peer support, opportunities to share lived experiences, and personalised connections within a free and accessible platform for the wider community.

As DiaPS officially launches, we are also looking for motivated community members to become verified users and active contributors within the platform.

Interested in becoming a verified user?
Contact the DIaPS team at info@sportsanddiabetes.eu

Download the app

READINGS ON DIABETES

Readings on Diabetes, presented to IDF Europe by Angelo Argenteri, MD, Maria Stella de Sabata, MA, and Andrea Ascoli Marchetti, MD, is a journey through the major diabetes milestones, one of the oldest and still most widespread diseases, with anecdotes, stories, historical facts and a very rich iconography.

Each month, the IDF Europe Newsletter presents a chapter from Readings on Diabetes, which can be downloaded in full here.

15. Charles Dotter: Diabetes Vasculopaty

This chapter tells the story of Charles Dotter, a visionary American radiologist whose ideas would quietly transform the future of vascular medicine. At a time when diabetes-related vascular complications often led to amputation, Dotter began questioning whether blocked arteries could be treated in a completely different way.

Driven by curiosity and persistence, he explored new techniques that many of his colleagues considered impossible or even dangerous. Through one particularly challenging case involving an elderly woman living
with insulin-dependent diabetes, Dotter’s unconventional approach would begin to change the way doctors understood vascular disease.

Blending medical history with innovation and human resilience, the chapter highlights how one bold idea opened the door to new possibilities for PwD and cardiovascular complications.

Are you curious to learn about the long quest to understand diabetes? Explore this fascinating story in Chapter 15 of Readings on Diabetes.

Readings on Diabetes

UPCOMING EVENTS ACROSS EUROPE

Liver Disease Prevention Village by ELPA
Esplanade – European Parliament, Brussels, June 1-5, 2026

“Economics of Obesity and Metabolic Health Summit”
Online, June 10, 2026, 17:00 CET | Read more and register here

European Association for the Study of Diabetes (EASD) 62nd Annual Meeting
Milan, September 28 – October 2, 2026 | For more information, click here

IDF Europe Symposium at EASD 2026
Milan, October 1, 2026, 10:30-12:00 CET | More information will be available soon

Follow us on social media!

Make sure to follow us to stay up to date with our latest news and events:

Do you want to know more about IDF Europe’s news and events? Please confirm that you are still happy to hear from us!

Give your consent here!

29 Μαΐου 2026

ΕΔΕ Αρχική Σελίδα, Εκδηλώσεις ΕΔΕ, Ηλεκτρονικά Μαθήματα

ΕΔΕ Webinar (Τετάρτη 3/6/2026, 20:00): “Θεραπεία ΣΔτ2 χωρίς υψηλό καρδιαγγειακό κίνδυνο”

Αγαπητοί συνάδελφοι,

Την Τετάρτη 3/6/2026 στις 20:00 πραγματοποιείται το webinar της Ελληνικής Διαβητολογικής Εταιρείας στο πλαίσιο των μετεκπαιδευτικών της μαθημάτων μέσω διαδικτύου.

ΘΕΜΑ:
“Θεραπεία ΣΔτ2 χωρίς υψηλό καρδιαγγειακό κίνδυνο”

ΠΡΟΕΔΡΕΙΟ / ΣΥΝΤΟΝΙΣΜΟΣ:

Α. Καμαράτος, Παθολόγος – Διαβητολόγος, MD, PhD, Διευθυντής ΕΣΥ, Επιστημονικός Υπεύθυνος Διαβητολογικού Κέντρου Γ.Ν. «ΤΖΑΝΕΙΟ», Πειραιάς, Συντονιστής Εκπαίδευσης Γενικών Ιατρών Γ.Ν. «ΤΖΑΝΕΙΟ», Πειραιάς

ΟΜΙΛΙΕΣ:

Ε. Γκούβερη, Επίκουρη Καθηγήτρια Παθολογίας – Μεταβολικών Νοσημάτων, Ιατρική Σχολή Δ.Π.Θ., Διαβητολογικό Κέντρο, Β ́ Πανεπιστημιακή Παθολογική Κλινική, Πανεπιστημιακό Γ.Ν. Αλεξανδρούπολης.
Ε. Ρίζος, Αναπληρωτής Καθηγητής Παθολογίας, Τμήμα Νοσηλευτικής, Πανεπιστήμιο Ιωαννίνων.

Σύνδεσμος βιντεοσκοπημένου webinar:

You must be logged in

Προσβλέποντας πάντα στην πολύτιμη ενεργό συμμετοχή σας.

Ο Πρόεδρος της Ε.Δ.Ε.
Κ. Μακρυλάκης

Ο Γεν. Γραμματέας της Ε.Δ.Ε.
Σ. Λιάτης

26 Μαΐου 2026

ΕΔΕ Αρχική Σελίδα, Νέα και Ανακοινώσεις

Ανακοίνωση ΕΔΕ για την απώλεια του Καθηγητή Ele Ferrannini

Η Ελληνική Διαβητολογική Εταιρεία εκφράζει τη βαθιά θλίψη της για την απώλεια του καθηγητή Ele Ferrannini, ενός εκ των σημαντικότερων ερευνητών παγκοσμίως στον τομέα του σακχαρώδους διαβήτη και του μεταβολισμού.

Ο Ele Ferrannini αφιέρωσε τη ζωή του στην έρευνα, συμβάλλοντας καθοριστικά στην κατανόηση της παθοφυσιολογίας της αντίστασης στην ινσουλίνη, του σακχαρώδους διαβήτη τύπου 2 και των καρδιομεταβολικών νοσημάτων. Το επιστημονικό του έργο, πρωτοποριακό και διεθνώς αναγνωρισμένο, επηρέασε βαθιά τη σύγχρονη διαβητολογία και εκπαίδευσε γενιές ερευνητών και κλινικών ιατρών.

Η συμμετοχή του σε δύο Πανελλήνια Διαβητολογικά Συνέδρια υπήρξε ιδιαίτερα τιμητική για την ΕΔΕ, καθώς το 1995 προσκλήθηκε να δώσει την Αρεταίειο Διάλεξη, ενώ το 2020 συμμετείχε ως ομιλητής σε Στρογγυλή Τράπεζα.

Η διεθνής διαβητολογική κοινότητα χάνει έναν σπουδαίο επιστήμονα, έναν οραματιστή ερευνητή και έναν άνθρωπο με εξαιρετική ακαδημαϊκή προσφορά.

Εκ μέρους του Διοικητικού Συμβουλίου και των μελών της Ελληνικής Διαβητολογικής Εταιρείας εκφράζουμε τα ειλικρινή μας συλλυπητήρια στην οικογένεια, τους συνεργάτες και τους μαθητές του.

Η μνήμη και το έργο του θα παραμείνουν ζωντανά στην παγκόσμια επιστημονική κοινότητα.

21 Μαΐου 2026

ΕΔΕ Αρχική Σελίδα, Νέα και Ανακοινώσεις

Επιστολή ΕΔΕ στον Υπ. Υγείας, κ. Ά. Γεωργιάδη – Υποστήριξη των θέσεων της ΕΛ.Ο.ΔΙ. σχετικά με τα κριτήρια αποζημίωσης συστημάτων συνεχούς καταγραφής γλυκόζης (CGM) σε ινσουλινοθεραπευόμενα άτομα με Σακχαρώδη Διαβήτη τύπου 2

Διαβάστε εδώ την επιστολή της ΕΔΕ.

Διαβάστε εδώ το αίτημα της ΕΛΟΔΙ για επίσημες διευκρινίσεις σχετικά με τις αποζημιώσεις CGM.

4 Μαΐου 2026

ΕΔΕ Αρχική Σελίδα, Πληροφορίες για το κοινό

Τι πρέπει να ξέρουμε για το ΑΝΘΕΚΤΙΚΟ ΑΜΥΛΟ;

¹Γραμματικού Μαρία, ¹Ζάχας Δημήτρης, ¹Τσάνα Μαρινέλα, ¹Χαρίση Λυδία
Επιμέλεια κειμένου: ¹Δημοσθενόπουλος Χαρίλαος
¹Διαιτολογικό Τμήμα, ΓΝΑ Λαϊκό

Ο όρος «ανθεκτικό άμυλο» ακούγεται όλο και πιο συχνά τα τελευταία χρόνια σχετικά με τον ρόλο του στη διατροφή για τον Σακχαρώδη Διαβήτη (ΣΔ). Πρόκειται για έναν τύπο υδατάνθρακα που φαίνεται να έχει ιδιαίτερο ενδιαφέρον, τόσο για τον γλυκαιμικό έλεγχο όσο και για την υγεία του εντέρου. Το άμυλο γενικά αποτελεί βασική πηγή ενέργειας για τον οργανισμό, ωστόσο δεν συμπεριφέρεται πάντα με τον ίδιο τρόπο. Η δομή του και ο τρόπος επεξεργασίας των τροφίμων επηρεάζουν σημαντικά το πόσο γρήγορα πέπτεται και απορροφάται, άρα και το πόσο αυξάνει τα επίπεδα γλυκόζης στο αίμα.

Πού βρίσκουμε ανθεκτικό άμυλο;

Τρόφιμα όπως τα ζυμαρικά, το ρύζι, οι πατάτες και τα δημητριακά είναι πλούσια σε άμυλο. Σε αντίθεση όμως με το «κοινό» άμυλο, το ανθεκτικό άμυλο δεν διασπάται στο λεπτό έντερο. Αντίθετα, φτάνει στο παχύ έντερο, όπου υφίσταται ζύμωση από τα βακτήρια του μικροβιώματος. Μέσα από αυτή τη διαδικασία παράγονται λιπαρά οξέα βραχείας αλύσου, όπως το βουτυρικό οξύ, τα οποία φαίνεται να έχουν σημαντικά οφέλη για την υγεία του εντέρου και όχι μόνο.

Το ανθεκτικό άμυλο μπορεί να βρεθεί φυσικά σε ορισμένα τρόφιμα, όπως τα όσπρια, τα δημητριακά ολικής άλεσης, καθώς και στις άγουρες (πράσινες) μπανάνες. Επιπλέον, μπορεί να σχηματιστεί και κατά την επεξεργασία των τροφίμων. Όταν, για παράδειγμα, μαγειρεύουμε αμυλούχα τρόφιμα όπως πατάτες, ρύζι ή ζυμαρικά και τα αφήνουμε να κρυώσουν, ένα μέρος του αμύλου μετατρέπεται σε ανθεκτικό άμυλο. Αυτό σημαίνει ότι ένα πιάτο μακαρόνια ή ρύζι που έχει μαγειρευτεί και καταναλώνεται την επόμενη ημέρα – ακόμη και αν ξαναζεσταθεί – μπορεί να έχει διαφορετική επίδραση στο σάκχαρο σε σχέση με το φρέσκο.

Ποια είναι τα πιθανά οφέλη;

Τα τελευταία χρόνια, αρκετές μελέτες έχουν εξετάσει τις πιθανές ευεργετικές δράσεις του ανθεκτικού αμύλου. Φαίνεται ότι μπορεί να συμβάλλει σε πιο ήπια αύξηση της γλυκόζης στο αίμα μετά το γεύμα, κάτι που είναι ιδιαίτερα σημαντικό για άτομα με ΣΔ ή προδιαβήτη. Παράλληλα, υπάρχουν ενδείξεις ότι μπορεί να βελτιώνει την ευαισθησία στην ινσουλίνη, βοηθώντας τον οργανισμό να διαχειρίζεται πιο αποτελεσματικά τη γλυκόζη. Μέσω της δράσης του στο έντερο, αυξάνει την παραγωγή βουτυρικού οξέος, το οποίο συνδέεται με καλύτερη λειτουργία του εντερικού φραγμού, μείωση της φλεγμονής και υποστήριξη ενός υγιούς μικροβιώματος. Επιπλέον, φαίνεται ότι μπορεί να επηρεάζει θετικά ορμόνες που σχετίζονται με το αίσθημα κορεσμού, όπως οι GLP-1 και PYY.

Παρόλα αυτά, είναι σημαντικό να τονιστεί ότι τα διαθέσιμα δεδομένα, αν και ενθαρρυντικά, δεν είναι ακόμη οριστικά. Τα οφέλη φαίνεται να είναι πιο έντονα σε άτομα με ήδη υπάρχουσες μεταβολικές διαταραχές και εξαρτώνται από την ποσότητα που καταναλώνεται. Επομένως, το ανθεκτικό άμυλο δεν αποτελεί «μαγική λύση», αλλά μπορεί να ενταχθεί ως μέρος μιας συνολικά ισορροπημένης διατροφής. Μικρές πρακτικές αλλαγές, όπως η συχνή κατανάλωση οσπρίων, η επιλογή προϊόντων ολικής άλεσης και η κατανάλωση ορισμένων αμυλούχων τροφίμων αφού πρώτα κρυώσουν, μπορούν να αυξήσουν την πρόσληψή του και ενδεχομένως να συμβάλουν θετικά στη διαχείριση του σακχάρου και στην υγεία του εντέρου.

ΒΙΒΛΙΟΓΡΑΦΙΑ:

Chen, R., Zhang, C., Xu, F., Yu, L., Tian, F., Chen, W. and Zhai, Q. (2023). Meta-analysis reveals gut microbiome and functional pathway alterations in response to resistant starch. Food & function, [online] 14(11), pp.5251–5263.
Xiong, K., Wang, J., Kang, T., Xu, F. and Ma, A. (2020). Effects of resistant starch on glycemic control: a systematic review and meta-analysis. British Journal of Nutrition, [online] pp.1–29.

4 Μαΐου 2026

ΕΔΕ Αρχική Σελίδα, Διάφορα, Νέα και Ανακοινώσεις

IDF Europe Newsletter – April 2026

<!–

FROM SILOES TO COLLABORATION
Advancing liver health through integrated action

As we mark World Liver Day, the European Liver Patients’ Association (ELPA) calls for urgent, coordinated action to address the growing and often overlooked link between liver disease, diabetes and other non-communicable diseases (NCDs).

Metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes share common risk factors and frequently coexist, significantly increasing the
risk of life-threatening complications. Yet across Europe, healthcare systems continue to treat these conditions separately. Too often, people are left to navigate complex systems on their own, moving from one specialist to another for each condition, without coordinated care. This fragmented approach delays diagnosis, limits access to appropriate care and fails to reflect the lived reality of people managing multiple, interconnected conditions.

This must change. We need a decisive shift towards prevention, early detection and integrated, person-centred care to prevent disease progression, reduce complications and improve quality of life.

At EU level, momentum is building through initiatives such as the European cardiovascular health plan, “The Safe Hearts Plan” and the “Healthier Together” NCD framework. These initiatives rightly prioritise prevention, early detection and integrated risk assessment for cardiovascular diseases (CVD) and diabetes. However, they remain incomplete without the full integration of liver health. MASLD is not only highly prevalent but also a major, independent risk factor for CVD.

ELPA therefore calls on the European Institutions and Member States to explicitly include liver health in EU CVD and NCD strategies, and to implement integrated screening
pathways that combine cardiovascular-renal-hepatic-metabolic risk assessments in primary care and in community settings. Simple, non-invasive tools already exist and can identify at-risk populations earlier and more effectively. Health systems must move beyond siloed, disease-specific models and adopt multidisciplinary approaches that address shared risk factors and comorbidities. Ignoring this opportunity means missing a critical window for prevention.

People with lived experience and patient organisations must be at the heart of this transformation. Their meaningful involvement is fundamental to building health systems that truly respond to people’s needs.

Stronger collaboration across the NCD community is also critical. ELPA is proud to be working alongside IDF Europe to advance a more integrated approach to prevention and care. This collaboration is reflected in joint efforts such as the “Bridge the Gap” initiative, which brings together the liver, diabetes, obesity, CVD and kidney communities to align advocacy and promote more coordinated approaches to these interconnected conditions. Our collaboration also includes participation in cross-community events and joint contributions to EU-level policy and advocacy efforts. This work will continue at the ELPA Liver Disease Prevention Village, taking place in front of the European Parliament in the first week of
June. Together, we will join forces to raise awareness, promote screening and prevention, and call on policymakers to take concrete action.

Now is the time to break down siloes, to act together and to make a coordinated, person-centred approach to liver disease, diabetes and other NCDs a reality across Europe.

Beatrice Credi
ELPA Head of Office

IDF EUROPE, NEWS, ACTIVITIES AND EVENTS

Save the date: IDF Europe Symposium at EASD

The IDF Europe Symposium, held during the EASD 62nd Annual Meeting, will take place on Thursday, 1 October, from 10:30 to 12:00 in Milan, and will be followed by a networking lunch.

More information about the Symposium will be available soon. Stay tuned!

IDF Europe Response to the Revision of the Medical Devices and in Vitro Diagnostic Medical Devices Regulation

As the EU moves to revise its medical devices framework (Devices Regulation (MDR) (EU) 2017/745 and In Vitro Diagnostic Medical Devices Regulation (IVDR) (EU) 2017/746), improving efficiency and supporting innovation remain central goals.

IDF Europe welcomes efforts to reduce bottlenecks and speed up access to new technologies, but simplification should not come at the expense of safety, transparency or trust.

In our response to the MDR & IVDR targeted revision, we highlight a key concern: the proposed revision risks shifting too much emphasis from pre-market scrutiny to post-market oversight, without the safeguards needed to ensure patients remain fully protected.

Read our response<!–

Read our response

“Diabetes for Women”
weekend in Poland

On March 6-8, Diabetes Advocate, Adrianna Maciejczyk, organised the “Cukrzyca dla Dziewczyn” (“Diabetes for Women”) Weekend in Poland, bringing together 40 women living with type 1 diabetes (T1D) for education, peer support and empowerment, covering topics from reproductive and mental health to physical activity. IDF Europe Board Member, Prof. Leszek Czupryniak, also participated, sharing insights on CVD risk in women living with diabetes.

We are proud to have endorsed this initiative, which highlights the importance of
advancing sex- and gender-sensitive approaches to diabetes care, a topic we also addressed during our World Diabetes Day 2025 event on women’s health at the European Parliament.

Read more<!–

MIRCIM 2026
Conference in Poland

IDF Europe is pleased to support the McMaster International Review Conference of Internal Medicine (MIRCIM), taking place on May 7–9 in Kraków, Poland.

The conference will gather health experts to discuss the latest evidence, studies and updates to clinical practice guidelines across internal medicine. The programme includes an Annual Update in Diabetology, covering topics from
T1D management to diabetes care in older age groups, as well as a presentation by IDF Europe Board Member, Prof. Leszek Czupryniak, on treatment options for people living with intermediate hyperglycaemia.

A 25% discount is available for all registration types using the code: IDFEurope25%

Person-centred diabetes care: join the San Marino Diabetes Congress

On May 29-30, the San Marino Association of PwD, “Vivere Meglio” (“Living Better”) will host a diabetes congress with the support of IDF Europe, bringing together diabetes advocates, healthcare professionals (HCPs), national diabetes associations and other experts.

The programme will cover key topics including the delivery of high-quality, integrated and person-centred care, the role of health systems, institutions, HCPs and patient associations, the social impact of diabetes and the importance of sport, access to innovation, equity and personalised approaches to care.

Registration is free and open until May 20.

Welcome to the team!

We are delighted to announce three new members to the IDF Europe team: Chantal Michael, Arthur Oury and Elena Thompson.

Chantal Michael joined our team in February as a Research Intern. With a background in Medical and Psychiatric Social Work and currently pursuing a Master’s degree in Global Health, she contributes to our research and policy work. She is particularly motivated by promoting equitable access to care and addressing health disparities.

Arthur Oury came on board in February as a Programme Assistant. Drawing on his background in Social Sciences and International Relations, he plays a key role in supporting project coordination and gathering insights to inform our policy activities. He has a strong interest in European affairs and a keen commitment to collaborative, impact-driven work.

Elena Thompson joined us in April as Communications and Social Media intern. With experience in digital communication and public relations, she leads on managing our social media channels and amplifying our projects and initiatives within the diabetes community. She is especially passionate about making information accessible and helping reduce health inequalities.

MEMBER NEWS

National educational
meeting in Bulgaria

On March 14, the Bulgarian Diabetes Association organised a national educational meeting in Sofia for representatives of its member associations under the theme “Why is diabetes management important?”.

The meeting focused on practical strategies to reduce the risk of diabetes-related complications and strengthen self-management education. Expert
speakers covered key topics such as diabetes management, eye health and prevention of diabetes foot complications. The event provided an opportunity for local diabetes association leaders to exchange knowledge and bring practical insights back to their communities, reinforcing the importance of prevention and proactive diabetes care.

Read more<!–

Celebrating World Health
Day in Uzbekistan

On April 7, marking World Health Day, the Charity Association of Persons with Disabilities and People with Diabetes in Uzbekistan (UMID) organised a community seminar, bringing together 54 residents from rural areas to raise awareness of diabetes prevention and the importance of healthy lifestyles.

Through presentations, videos, interactive sessions, as well as blood glucose and blood pressure checks, the association highlighted the importance of community-based health initiatives in supporting early detection of diabetes and its
complications. It also reinforced the need to ensure equitable access to prevention, diagnosis, education and care for all, particularly in underserved communities.

Read more<!–

Polish Diabetes Association hosts Leaders’ Forum and T2D advocacy workshop

On April 23-24, the 7^thLeaders’ Forum of the Polish Diabetes Association brought together leaders and representatives of people living with diabetes (PwD), marking its 45th anniversary and 35 years as a member of the International Diabetes Federation.

Alongside the Forum, a T2D advocacy workshop led by Oliwia Kaczmarek and
supported by IDF Europe, equipped participants with skills in storytelling, tackling stigma and engaging with decision-makers. With IDF Europe’s Communication & Engagement Manager, Marian Brennan contributing as facilitator and supported by T2GETHER mentors, Christian Petersen, Janne Mikkonen, Oliwia Kacsmarek and Sehnaz Karadeniz, the programme empowered participants living with T2D to translate lived experience into impactful advocacy at national and European levels.

During the event, we were honoured to receive the PRODIABETES Award in recognition of outstanding commitment and contribution to the diabetes community. We sincerely thank the Association for this
meaningful recognition, which means a great deal to our entire team and reflects our ongoing efforts across Europe. We are equally proud that Prof. Leszek Czupryniak, IDF Europe Board Member, was also recognised with an award for his contribution to raising awareness of diabetes and his active participation in public health debates, helping to drive systemic changes that improve the lives of PwD.

Read more<!–

YOUTH PLATFORM

IDF Europe at Thriveabetes 2026

On April 18, IDF Europe Board Member, Jaivir Pall and Youth Coordinator, Joana Amorim, joined Thriveabetes 2026 in Dublin, a conference organised by, and for, people living with T1D. Thriveabetes aims to inform, motivate and inspire the diabetes community by creating a space where no person living with T1D feels alone. The event featured several sessions led by diabetes experts, a Diabetes Technology Exhibition and a Diabetes Research Poster Display.

With a dedicated booth, we showcased the IDF Europe Youth Programme and connected with young PwD and parents interested in becoming part of the community. It was also a valuable opportunity to strengthen relationships with like-minded organisations and raise the visibility of youth advocacy in diabetes across Europe.

Read more about our Youth Programme<!–

UNDERSTANDING DIABETES

Diabetes as a marker of healthcare system resilience

Diabetes is a chronic condition that cuts across all aspects of healthcare systems – from prevention and screening to early intervention, long-term management and complication prevention – requiring coordinated care, access to medicines and technologies, and multidisciplinary teams across all levels of care. It is closely linked to other chronic condtions such as obesity, cardiovascular, liver, kidney and brain diseases, with complications accounting for up to 75% of its costs. Addressing diabetes and its related conditions earlier and more effectively can significantly reduce this burden while strengthening workforce participation and productivity. This requires moving beyond
fragmented approaches toward integrated, person-centred care.

Despite the alarming rise in NCDs, Europe continues to treat the symptoms of a crisis while ignoring its underlying drivers. By the time an EU citizen is diagnosed with a cardiovascular complication, a decade of opportunity for prevention and intervention has already been lost. The EU Safe Hearts Plan is our chance to stop the domino effect through which obesity and diabetes lead to CVD –turning a fragmented system into pillar of resilience for EU’s economy, health systems and its people. For too long, we have addressed interconnected health challenges through siloed approaches. there is a clear opportunity to align screening,
prevention and management of interconnected conditions – supporting more resilient health systems while reinforcing Europe’s long-term competitiveness.

Read more in our article in The Parliament magazine and in the recent EFPIA guest blog co-authored by our Regional Manager, Elisabeth Dupont and Christina Holton Moloney, Co-Chair, EFPIA Obesity Platform:

The Parliament magazine:
“Tackling diabetes is key to creating a healthier, more competitive Europe“

EFPIA guest blog:
“The €240 billion leak: Why Europe’s health resilience starts with integrated obesity, diabetes and CVD health checks“

WHAT WE ARE READING

WHO Europe | Norway’s new legislation shields children from marketing of unhealthy foods

Norway has introduced new legislation banning the marketing of unhealthy food and drinks to children, aiming to tackle rising rates of NCDs. The measure, aligned with WHO recommendations, restricts both traditional and digital advertising and reflects growing international momentum to create healthier environments for children. Norway’s approach is seen as a strong example for other countries in the WHO European Region to follow. Read more

The Lancet Diabetes & Endocrinology | Sleep your way to better metabolic health

A new editorial in The Lancet Diabetes & Endocrinology highlights the often-overlooked link between sleep and metabolic health. It underscores how poor sleep can increase the risk chronic conditions such as T2D, CVD and obesity, particularly in children, through complex, bidirectional mechanisms. The editorial also points to growing evidence that improving sleep could offer a practical and scalable approach to supporting metabolic health. Read more

WHO Europe | New WHO database helps countries turn health data into better policy

WHO has launched the Health Information Systems Governance (HISGOV) database to help countries across the European Region turn health data into better policy. Co-funded by the EU, it compiles nearly 70 indicators on data governance, digital health systems and interoperability. The platform enables comparison across countries, highlights gaps and supports evidence-based decisions to strengthen health systems and improve outcomes. Read more

OECD | Scaling artificial intelligence in health

A new OECD report highlights the potential of artificial intelligence (AI) to improve healthcare if deployed responsibly. It outlines key barriers such as fragmented data, regulatory uncertainty and workforce gaps. To guide countries, it introduces a policy checklist covering enablers, safeguards, public engagement and trustworthy AI deployment, aiming to support coherent strategies, shared learning and balanced innovation across health systems. Read more

WHO Europe | A snapshot of AI in health care across EU Member States

WHO Europe released its first comprehensive assessment of AI in healthcare across the 27 EU Member States. The report shows widespread adoption, with most countries already using AI in diagnostics and patient support, alongside growing investment in workforce training and governance. It highlights the need for stronger skills, public engagement and shared standards to ensure AI improves patient care safely, equitably and with public trust. Read more

EU RESEARCH PROJECTS

ASSESS DHT survey
on DHT evaluation

IDF Europe is part of ASSESS DHT, a Horizon 2020 project aiming to boost the adoption of trustworthy and effective Digital Health Technologies (DHT) across Europe.

Consortium partners are conducting a European survey to increase understanding of how people with lived experience and HCPs can meaningfully contribute to the evaluation of DHT.

The survey is open until May 22

Take the survey<!–

Take the survey

MOVEUP Europe Cup
in Prishtina

IDF Europe is a project partner of MOVEUP, an Erasmus+ project aiming to make physical activity more accessible to people living with T2D and other chronic health conditions.

On April 25-26, 34 participants from Italy, Romania and Kosovo gathered in Prishtina for the MOVEUP Europe Cup, a celebration of walking football, walking basketball and catchball. The event provided an
opportunity for participants involved in the project in their own countries to come together, connect and share experiences with others from across Europe.

DigiCare4You updates

IDF Europe is proud to be part of the DigiCare4You Horizon 2020 project, which aims to improve early prevention and management of T2D and hypertension (HTN).

DigiCare4You final event

The DigiCare4You final event took place on April 29 in Brussels. This high-level gathering brought together policymakers, public health leaders, PwD and other stakeholders to discuss the future of innovative solutions for the prevention and management of T2D and HTN. Participants gained insights into the project’s key achievements and outcomes and also had the opportunity to contribute to the development of a roadmap supporting implementation at national level.

Join the webinar: “From pilot to policy: scaling
DigiCare4You for better NCD Care”

Join the upcoming DigiCare4You interactive webinar on May 19, at 15:00-16:30, to explore how the project is moving beyond pilot initiatives toward real policy-level impact in the prevention and management of NCDs such as T2D and HTN.

The session will feature key findings and results from the project, alongside practical insights on how to implement and scale digital health interventions for NCD prevention and management in your own country. Through expert presentations and dynamic panel discussions, participants will gain a clearer understanding of both the challenges and
opportunities involved in integrating digital health solutions into national systems.

Bulgarian-language video on hypertension

To broaden access to clear and reliable information to a wider audience, the DigiCare4You educational video on HTN has now been translated into Bulgarian.

The video is also available in Albanian, English, Greek and Spanish.

Watch the videos<!–

Watch the videos

Participant interview
with Zacharias Terzakis

DigiCare4You recently published an interview with Zacharias Terzakis, a participant from Greece living with intermediate hyperglycaemia. In the interview, he talks about his motivation, the positive changes he’s noticed and challenges of the programme.

Read the interview<!–

Read the interview

DiaPs: a new digital peer support tool for sport and diabetes

IDF Europe is part of the Erasmus+ project Sports & Diabetes: Diabetes Digital Peer S(up)port (DiaPs), which has been working on developing an app for peer support where PwD can share their experience of managing their condition during sport activities.

Co-created with people living with T1D, the DiaPS app has recently been launched. It aims to empower, inform and connect users, supporting them to stay active in sport with confidence, stay engaged and foster role models for future generations.

As part of the project, PwD, athletes, coaches and PE teachers, HCPs, parents and anyone passionate about sports and diabetes are invited to become DiaPs Ambassadors – exploring the app early, sharing their experience, and helping shape its future development.

Try the DiaPs app<!–

Try the DiaPs app

Become a DiaPs ambassador<!–

Become a DiaPs ambassador

READINGS ON DIABETES

Each month, the IDF Europe Newsletter presents a chapter from Readings on Diabetes, which can be downloaded in full here.

14. Scipione Riva Rocci: the sphygmomanometer

In the quiet Ligurian village of San Michele di Pagana rests Scipione Riva Rocci, a name unfamiliar to many, yet central to one of the most important medical tools still in use today: the sphygmomanometer. Simple in design and unchanged in principle for over a century, this device made it possible to measure blood pressure easily and reliably – an essential step forward in modern medicine and in the care of PwD.

Driven by curiosity and influenced by the emerging link between medicine and mechanics, Riva Rocci developed a practical solution at a time when measuring blood pressure was complex and
unreliable. Notably, he chose never to patent his invention, allowing it to spread freely and benefit patients worldwide.

Are you curious to learn about the long quest to understand diabetes? Explore this fascinating story in Chapter 14 of Readings on Diabetes.

Readings on Diabetes<!–

Readings on Diabetes

UPCOMING EVENTS ACROSS EUROPE

Webinar: “The pulse of tomorrow: shifting the paradigm for NCDs in global health architecture”
Online, May 12, 2026, 14:00-15:00 CET | Read more and register here

Webinar: “From pilot to policy: scaling DigiCare4You for better NCD Care”
Online, May 19, 2026, 15:00-16:30 CET | Read more and register here

European Association for the Study of Diabetes (EASD) 62nd Annual Meeting
Milan, September 28 – October 2, 2026 | For more information, click here

IDF Europe Symposium at EASD 2026
Milan, October 1, 2026, 10:30-12:00 CET | More information will be available soon

Follow us on social media!

Make sure to follow us to stay up to date with our latest news and events:

Category: Αρχική Σελίδα

Webinar ΕΔΕ για το κοινό (29/6/2026, 20:30)

IDF Europe newsletter – May 2026

Accelerating diabetes innovation in Europe:

getting it right for people living with diabetes

IDF EUROPE, NEWS, ACTIVITIES AND EVENTS

MEMBER NEWS

YOUTH PLATFORM

MMD NEWS

WHAT WE ARE READING

UNDERSTANDING DIABETES

EU RESEARCH PROJECTS

READINGS ON DIABETES

UPCOMING EVENTS ACROSS EUROPE

ΕΔΕ Webinar (Τετάρτη 3/6/2026, 20:00): “Θεραπεία ΣΔτ2 χωρίς υψηλό καρδιαγγειακό κίνδυνο”

Ανακοίνωση ΕΔΕ για την απώλεια του Καθηγητή Ele Ferrannini

Τι πρέπει να ξέρουμε για το ΑΝΘΕΚΤΙΚΟ ΑΜΥΛΟ;

IDF Europe Newsletter – April 2026

FROM SILOES TO COLLABORATION
Advancing liver health through integrated action

IDF EUROPE, NEWS, ACTIVITIES AND EVENTS

MEMBER NEWS

YOUTH PLATFORM

UNDERSTANDING DIABETES

WHAT WE ARE READING

EU RESEARCH PROJECTS

READINGS ON DIABETES

UPCOMING EVENTS ACROSS EUROPE

ΕΔΕ Webinar (Τετάρτη 6/5/2026, 20:00): “Συνεχής καταγραφή σακχάρου αίματος”

ΚΑΛΟΚΑΙΡΙΝΗ ΔΙΑΤΡΟΦΗ ΚΑΙ ΔΙΑΒΗΤΗΣ

Εκπαιδευτικό Πρόγραμμα CME της MedEA – Medical Education Academy με θέμα: “MANAGING PRE-DIABETES/INTERMEDIATE HYPERGLYCAEMIA & TYPE 2 DIABETES 2026: GUIDELINES ON MONITORING & MULTISYSTEM HEALTH”

Accelerating diabetes innovation in Europe:

getting it right for people living with diabetes

IDF EUROPE, NEWS, ACTIVITIES AND EVENTS

MEMBER NEWS

YOUTH PLATFORM

MMD NEWS

WHAT WE ARE READING

UNDERSTANDING DIABETES

EU RESEARCH PROJECTS

READINGS ON DIABETES

UPCOMING EVENTS ACROSS EUROPE

Σύνδεση

FROM SILOES TO COLLABORATION Advancing liver health through integrated action

IDF EUROPE, NEWS, ACTIVITIES AND EVENTS

MEMBER NEWS

YOUTH PLATFORM

UNDERSTANDING DIABETES

WHAT WE ARE READING

EU RESEARCH PROJECTS

READINGS ON DIABETES

UPCOMING EVENTS ACROSS EUROPE

Σύνδεση

FROM SILOES TO COLLABORATION
Advancing liver health through integrated action